Medicinal plants used in the treatment of tuberculosis - Ethnobotanical and ethnopharmacological approaches

Biotechnology Advances

Volumn 44, Issue , 2020, Pages

  Sharifi Rad, Javad ^a   Salehi, Bahare ^a   Stojanović Radić, Zorica Z ^b   Fokou, Patrick Valere Tsouh ^c,d   Sharifi Rad, Marzieh ^e   Mahady, Gail B ^f   Sharifi Rad, Majid ^e   Masjedi, Mohammad Reza ^a   Lawal, Temitope O ^f,g   Ayatollahi, Seyed Abdulmajid ^a   Masjedi, Javid ^a   Sharifi Rad, Razieh ^e   Setzer, William N ^h   Sharifi Rad, Mehdi ⁱ   Kobarfard, Farzad ^a   Rahman, Atta ur ^j   Choudhary, Muhammad Iqbal ^j   Ata, Athar ^k   Iriti, Marcello ^l  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF NI   (Serbia)

^c University of Ghana   (Ghana)

^d UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^e UNIVERSITY OF ZABOL   (Iran)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^g UNIVERSITY OF IBADAN   (Nigeria)

^h University of Alabama in Huntsville   (United States)

ⁱ ZABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^j UNIVERSITY OF KARACHI   (Pakistan)

^k UNIVERSITY OF WINNIPEG   (Canada)

^l UNIVERSITY OF MILAN   (Italy)

more..

Author keywords

Antimycobacterial agents; Evidence based medicine; Herbal medicine; Multi drug resistance; Mycobacterium; Traditional healing systems

Indexed keywords

DRUG PRODUCTS; MARINE BIOLOGY; MEDICAL APPLICATIONS; TUBES (COMPONENTS);

ANTIMYCOBACTERIAL ACTIVITY; ANTITUBERCULOSIS AGENTS; ENVIRONMENTAL ADAPTABILITY; HEALTHCARE STRUCTURES; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; RANDOMIZED CLINICAL TRIALS; WORLD HEALTH ORGANIZATION;

DRUG THERAPY;

ANTIBIOTICS; BACTERIAL DISEASE; DRUG RESISTANCE; ETHNOBOTANY; GENETIC ANALYSIS; HEALTH CARE; INFECTIOUS DISEASE; MEDICINAL PLANT; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

FUNGI; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

ANTIINFECTIVE AGENT; TUBERCULOSTATIC AGENT;

HUMAN; MEDICINAL PLANT; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

ANTI-INFECTIVE AGENTS; ANTITUBERCULAR AGENTS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; PLANTS, MEDICINAL; TUBERCULOSIS;

EID: 85090348998     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2020.107629     Document Type: Review

References (127)

1. Abbruzzese, M.R., Delaha, E.C., Garagusi, V.F., Absence of antimycobacterial synergism between garlic extract and antituberculosis drugs. Diagn. Microbiol. Infect. Dis. 8:2 (1987), 79–85.
2. Adhvaryu, M., Vakharia, B., Drug-resistant tuberculosis: emerging treatment options. Clin. Pharmacol. 3 (2011), 51–67.
3. Ahmad, I., Aqil, F., Owais, M., Modern Phytomedicine: Turning Medicinal Plants into Drugs. 2006, Wiley, USA.
4. Ahmed, H.M., Ethnopharmacobotanical study on the medicinal plants used by herbalists in Sulaymaniyah Province, Kurdistan, Iraq. J. Ethnobiol. Ethnomed., 12, 2016, 8.
5. Ahuja, S., Ahuja, S., Ahuja, U., Nirgundi (Vitex negundo) – Nature's gift to mankind. Asian Agrihist. 19 (2015), 5–32.
6. Alvin, A., Miller, K.I., Neilan, B.A., Exploring the potential of endophytes from medicinal plants as sources of antimycobacterial compounds. Microbiol. Res. 169:7–8 (2014), 483–495.
7. Antony, M., James, J., Misra, C.S., Sagadevan, L.D.M., Veettil, A.T., Thankamani, V., Anti mycobacterial activity of the plant extracts of Alstonia scholaris. Int. J. Curr. Pharm. Res. 4 (2012), 40–422.
8. Arai, M., Yamano, Y., Setiawan, A., Kobayashi, M., Identification of the target protein of agelasine D, a marine sponge diterpene alkaloid, as an anti-dormant mycobacterial substance. Chem. Bio.Chem. 15:1 (2014), 117–123.
9. Arya, V., A review on anti-tubercular plants. Int. J. Phar.Tech Res. 3:2 (2011), 872–880.
10. Atanasov, A.G., Waltenberger, B., Pferschy-Wenzig, E.M., Linder, T., Wawrosch, C., Uhrin, P., Temml, V., Wang, L., Schwaiger, S., Heiss, E.H., Rollinger, J.M., Schuster, D., Breuss, J.M., Bochkov, V., Mihovilovic, M.D., Kopp, B., Bauer, R., Dirsch, V.M., Stuppner, H., Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnol. Adv. 33:8 (2015), 1582–1614.
11. Ayyanar, M., Ignacimuthu, S., Medicinal uses and pharmacological actions of five commonly used Indian medicinal plants: a mini-review. Iran. J. Pharmacol. Ther. 7 (2008), 107–114.
12. Batugal, P.A., Kanniah, J., Young, L.S., Oliver, J.T., Medicinal Plants Research In Asia. 2004, International Plant Genetic Resources Institute – Regional Office for Asia, the Pacific and Oceania (IPGRI-APO), Serdang, Selangor DE, Malaysia.
13. Bedi, R.S., Management of tuberculosis in special situations. Lung India 22 (2005), 138–141.
14. Bernaitis, L., Shenoy, V.P., Ashok, M., Nath, M., Shenoy, R.P., Effects of selective medicinal plants against multi drug resistance Mycobacterium tuberculosis strains. Res. J. Pharm. Biol. Chem. Sci. 4:3 (2013), 812–817.
15. Bhatter, P.D., Gupta, P.D., Birdi, T.J., Activity of medicinal plant extracts on multiplication of Mycobacterium tuberculosis under reduced oxygen conditions using intracellular and axenic assays. Int. J. Microbiol., 2016, 2016, 8073079.
16. Birdi, T., D'souza, D., Tolani, M., Daswani, P., Nair, V., Tetali, P., Toro, J.C., Hoffner, S., Assessment of the activity of selected Indian medicinal plants against Mycobacterium tuberculosis: a preliminary screening using the Microplate Alamar Blue Assay. Eur. J. Med. Plants. 2:4 (2012), 308–323.
17. Bunalema, L., Anti-mycobacterial Activity and Acute Toxicity of Erythrina abyssinica, Cryptolepis sanguinolenta and Solanum incanum. 2010, Makerere University Kampala, Uganda.
18. Camacho-Corona, M.R., Ramírez-Cabrera, M.A., Santiago, O.G., Garza-González, E., Palacios, I.P., Luna-Herrera, J., Activity against drug resistant-tuberculosis strains of plants used in Mexican traditional medicine to treat tuberculosis and other respiratory diseases. Phytother. Res. 22:1 (2008), 82–85.
19. Cardona, P., Ruiz-Manzano, J., On the nature of Mycobacterium tuberculosis-latent bacilli. Eur. Respir. J. 24:6 (2004), 1044–1051.
20. Chandra, S., Rawat, D.S., Medicinal plants of the family Caryophyllaceae: a review of ethno-medicinal uses and pharmacological properties. Integr. Med. Res. 4:3 (2015), 123–131.
21. Chiang, C.Y., Centis, R., Migliori, G.B., Drug-resistant tuberculosis: past, present, future. Respirology 15:3 (2010), 413–432.
22. Coronado-Aceves, E.W., Sánchez-Escalante, J.J., López-Cervantes, J., Robles-Zepeda, R.E., Velázquez, C., Sánchez-Machado, D.I., Garibay-Escobar, A., Antimycobacterial activity of medicinal plants used by the Mayo people of Sonora. Mexico. J. Ethnopharmacol. 190 (2016), 106–115.
23. Cragg, G.M., Newman, D.J., Natural products: a continuing source of novel drug leads. Biochim. Biophys. Acta. 1830:6 (2013), 3670–3695.
24. Daletos, G., Ancheeva, E., Chaidir, C., Kalscheuer, R., Proksch, P., Antimycobacterial metabolites from marine invertebrates. Archiv. Der Pharmazie. 349 (2016), 763–773.
25. Davoodi, H., Ghaemi, E., Mazandarani, M., Shakeri, F., Javid, S., Klishadi, M., Anti-mycobacterial and anti-inflammatory activity of Peganum harmala. J. Chem. Pharm. Res. 7:4 (2015), 1611–1616.
26. Debnath, P.K., Chattopadhyay, J., Mitra, A., Adhikari, A., Alam, M.S., Bandopadhyay, S.K., Hazra, J., Adjunct therapy of Ayurvedic medicine with anti tubercular drugs on the therapeutic management of pulmonary tuberculosis. J. Ayurveda Integr. Med. 3:3 (2012), 141–149.
27. Delaha, E.C., Garagusi, V.F., Inhibition of mycobacteria by garlic extract (Allium sativum). Antimicrob. Agents. Chemother. 27:4 (1985), 485–486.
28. Deveci, A., Coban, A.Y., Tanrıverdi, Ç.Y., Acicbe, O., Taşdelen, F.N., Akgüneş, A., Ozatlı, D., Uzun, M., Durupınar, B., In vitro effect of Ankaferd Blood Stopper®, a plant extract against Mycobacterium tuberculosis Isolates. Mikrobiyol. Bul. 47:1 (2013), 71–78.
29. Dhanabal, S.P., Lall, N., Pavithra, N., Chaitanya, M.V.N.L., Natural products as an important leads for discovery of new antitubercular agents: a review. Int. J. Pharm. Pharm. Sci. 7:10 (2015), 2–7.
30. Diacon, A.H., Pym, A., Grobusch, M., Patientia, R., Rustomjee, R., Page-Shipp, L., Pistorius, C., Krause, R., Bogoshi, M., Churchyard, G., Venter, A., Allen, J., Palomino, J.C., De Marez, T., Van Heeswijk, R.P., Lounis, N., Meyvisch, P., Verbeeck, J., Parys, W., De Beule, K., Andries, K., Mc Neeley, D.F., The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N Engl. J. Med. 360:23 (2009), 2397–2405.
31. Dini, C., Fabbri, A., Geraci, A., The potential role of garlic (Allium sativum) against the multi-drug resistant tuberculosis pandemic: a review. Ann Ist Super Sanita. 47:4 (2011), 465–473.
32. Dong, M., Pfeiffer, B., Altmann, K.H., Recent developments in natural product-based drug discovery for tuberculosis. Drug Discov. Today. 22:3 (2017), 585–591.
33. Faleyimu, O.I., Akinyemi, O., Adejoba, O.R., Herbal solution to the treatment of tuberculosis infection in Kaduna south local government, Kaduna, Nigeria. J. Environ. Ext. 8:3 (2009), 40–43.
34. Farshidpour, M., Ebrahimi, G., Mirsaeidi, M., Multidrug-resistant tuberculosis treatment with linezolid-containing regimen. Int. J. Mycobacteriol. 2:4 (2013), 233–236.
35. Ganihigama, D.U., Sureram, S., Sangher, S., Hongmanee, P., Aree, T., Mahidol, C., Ruchirawat, S., Kittakoop, P., Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis. Eur. J. Med. Chem. 89 (2015), 1–12.
36. Gautam, R., Saklani, A., Jachak, S.M., Indian medicinal plants as a source of antimycobacterial agents. J. Ethnopharmacol. 110:2 (2007), 200–234.
37. Gautam, H.A., Sharma, R., Rana, A.C., Review on herbal plants useful in tuberculosis. Int. Res. J. Pharm. 3:7 (2012), 64–67.
38. Ghanashyam, B., Changing the game for multidrug-resistant tuberculosis. Lancet 387:10024 (2016), 1149–1150.
39. Green, E., Samie, A., Obi, C.L., Bessong, P.O., Ndip, R.N., Inhibitory properties of selected South African medicinal plants against Mycobacterium tuberculosis. J. Ethnopharmacol. 130:1 (2010), 151–157.
40. Gupta, K., Viswanathan, R., Combined action of streptomycin and chloramphenicol with plant antibiotics against Tubercle bacilli. Part I: streptomycin and chloramphenicol with cepharanthine. Part II: streptomycin and allicin. Antibiot. Chemother. 5:1 (1955), 24–27.
41. Gupta, R., Thakur, B., Singh, P., Singh, H.B., Sharma, V.D., Katoch, V.M., Chauhan, S.V., Anti-tuberculosis activity of selected medicinal plants against multi-drug resistant Mycobacterium tuberculosis isolates. Indian J. Med. Res. 131 (2010), 809–813.
42. Gupta, P., Bhatter, P., D'souza, D., Tolani, M., Daswani, P., Tetali, P., Birdi, T., Evaluating the anti Mycobacterium tuberculosis activity of Alpinia galanga (L.) Willd. axenically under reducing oxygen conditions and in intracellular assays. BMC Complement. Altern. Med., 4(14), 2014, 84.
43. Hannan, A., Ikram Ullah, M., Usman, M., Hussain, S., Absar, M., Javed, K., Anti-mycobacterial activity of garlic (Allium sativum) against multi-drug resistant and non-multi-drug resistant Mycobacterium tuberculosis. Pak. J. Pharm. Sci. 24 (2011), 81–85.
44. Holtz, T., Cegielski, J., Origin of the term XDR-TB. Eur. Respir. J., 30(2), 2007, 396.
45. Holzgrabe, U., New griselimycins for treatment of tuberculosis. Chem. Biol. 22:8 (2015), 981–982.
46. Hussain, S., Haq, A., Nisar, M., Ahmad, T., Bhardwaj, P., Evaluation of in-vitro anti-mycobacterial activity and isolation of active constituents from Crocus sativus L. (Iridaceae). Asian J. Med. Pharma. Res. 4 (2014), 130–135.
47. Jahanpour, S., Ghazisaidi, K., Davoodi, H., Mazandarani, M., Samet, M., Jahanpour, N., Ghaemi, E.A., Antimicrobial effects of folk medicinal plants from the North of Iran against Mycobacterium tuberculosis. Arch. Pediatr. Infect. Dis., 3(1 TB), 2015, e18098.
48. Jiang, R.H., Xu, H.B., Fu, J., Outcomes of Chinese herb medicine for the treatment of multidrug-resistant tuberculosis: a systematic review and meta-analysis. Complement. Ther. Med. 23:4 (2015), 544–554.
49. Jyoti, M.A., Zerin, T., Kim, T.H., Hwang, T.S., Jang, W.S., Nam, K.W., Song, H.Y., In vitro effect of ursolic acid on the inhibition of Mycobacterium tuberculosis and its cell wall mycolic acid. Pulm. Pharmacol. Ther. 33 (2015), 17–24.
50. Jyoti, M.A., Nam, K.W., Jang, W.S., Kim, Y.H., Kim, S.K., Lee, B.E., Song, H.Y., Antimycobacterial activity of methanolic plant extract of Artemisia capillaris containing ursolic acid and hydroquinone against Mycobacterium tuberculosis. J. Infect. Chemother. 22:4 (2016), 200–208.
51. Kaufmann, S., Evans, T.G., Hanekom, W.A., Tuberculosis vaccines: time for a global strategy. Sci. Transl. Med., 7, 2015, 276fs8.
52. Kinghorn, A.D., Pan, L., Fletcher, J.N., Chai, H., The relevance of higher plants in lead compound discovery programs. J. Nat. Prod. 74:6 (2011), 1539–1555.
53. Koul, A., Arnoult, E., Lounis, N., Guillemont, J., Andries, K., The challenge of new drug discovery for tuberculosis. Nature 469 (2011), 483–490.
54. Kumar, P., Singh, A., Sharma, U., Singh, D., Dobhal, M., Singh, S., Anti-mycobacterial activity of plumericin and isoplumericin against MDR Mycobacterium tuberculosis. Pulm. Pharmacol. Ther. 26:3 (2013), 332–335.
55. Lakshmanan, D., Werngren, J., Jose, L., Suja, K.P., Nair, M.S., Varma, R.L., Mundayoor, S., Hoffner, S., Kumar, R.A., Ethyl p-methoxycinnamate isolated from a traditional anti-tuberculosis medicinal herb inhibits drug resistant strains of Mycobacterium tuberculosis in vitro. Fitoterapia 82:5 (2011), 757–761.
56. Lall, N., Meyer, J.J.M., In vitro inhibition of drug-resistant and drug-sensitive strains of Mycobacterium tuberculosis by ethnobotanically selected South African plants. J. Ethnopharmacol. 66:3 (1999), 347–354.
57. Lalvani, A., Sridhar, S., Von Reyn, C.F., Tuberculosis vaccines: time to reset the paradigm?. Thorax 68:12 (2013), 1092–1094.
58. Lawal, I.O., Grierson, D.S., Afolayan, A.J., Phytotherapeutic information on plants used for the treatment of tuberculosis in Eastern Cape Province, South Africa. Evid. Based Complement. Alternat. Med., 2014, 2014, 735423.
59. Lee, H., Suh, J.W., Anti-tuberculosis lead molecules from natural products targeting Mycobacterium tuberculosis ClpC1. J. Ind. Microbiol. Biotechnol. 43:2–3 (2016), 205–212.
60. Lee, M., Cho, S.N., Barry, C.E. 3rd, Song, T., Kim, Y., Jeong, I., Linezolid for XDR-TB—final study outcomes. N. Engl. J. Med. 373:3 (2015), 290–291.
61. Leitão, F., Leitão, S.G., De Almeida, M.Z., Cantos, J., Coelho, T., Da Silva, P.E., Medicinal plants from open-air markets in the State of Rio de Janeiro Brazil as a potential source of new antimycobacterial agents. J. Ethnopharmacol. 149:2 (2013), 513–521.
62. León-Díaz, R., Meckes, M., Said-Fernández, S., Molina-Salinas, G.M., Vargas-Villarreal, J., Torres, J., Luna-Herrera, J., Jiménez-Arellanes, A., Antimycobacterial neolignans isolated from Aristolochia taliscana. Mem. Inst. Oswaldo Cruz. 105:1 (2010), 45–51.
63. Ling, L.L., Schneider, T., Peoples, A.J., Spoering, A.L., Engels, I., Conlon, B.P., Mueller, A., Schäberle, T.F., Hughes, D.E., Epstein, S., Jones, M., Lazarides, L., Steadman, V.A., Cohen, D.R., Felix, C.R., Fetterman, K.A., Millett, W.P., Nitti, A.G., Zullo, A.M., Chen, C., Lewis, K., A new antibiotic kills pathogens without detectable resistance. Nature 517:7535 (2015), 455–459.
64. Liu, Q., Garner, P., Wang, Y., Huang, B., Smith, H., Drugs and herbs given to prevent hepatotoxicity of tuberculosis therapy: systematic review of ingredients and evaluation studies. BMC Public Health, 8, 2008, 365.
65. Lu, J., Ye, S., Qin, R., Deng, Y., Li, C.P., Effect of Chinese herbal medicine extracts on cell-mediated immunity in a rat model of tuberculosis induced by multiple drug-resistant bacilli. Mol. Med. Rep. 8:1 (2013), 227–232.
66. Maarisit, W., Abdjul, D.B., Yamazaki, H., Kato, H., Rotinsulu, H., Wewengkang, D.S., Sumilat, D.A., Kapojos, M.M., Ukai, K., Namikoshi, M., Anti-mycobacterial alkaloids, cyclic 3-alkyl pyridinium dimers, from the Indonesian marine sponge Haliclona sp. Bioorg. Med. Chem. Lett. 27:15 (2017), 3503–3506.
67. Madikizela, B., Pharmacological Evaluation of South African Medicinal Plants Used for Treating Tuberculosis and Related Symptoms South Africa. 2014, University of KwaZulu-Natal.
68. Mangtani, P., Abubakar, I., Ariti, C., Beynon, R., Pimpin, L., Fine, P.E.M., Rodrigues, L.C., Smith, P.G., Lipman, M., Whiting, P.F., Sterne, J.A., Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin. Infect. Dis. 58:4 (2014), 470–480.
69. Mansour, A., Sepideh, S., Mohammad, H., Antimycobacterial activity of partial purified extract of Allium ascalonicum. Jundishapur J. Microbiol. 2:40 (2009), 144–147.
70. Mariita, M.A.R., Efficacy of Medicinal Plants Used by Communities Around Lake Victoria Region and the Samburu Against Mycobacteria, Selected Bacteria and Candida albicans. 2006, Kenyatta University, Kenya.
71. Masjedi, M.R., Farnia, P., Sorooch, S., Pooramiri, M.V., Mansoori, S.D., Zarifi, A.Z., Velayati, A.A., Hoffner, S., Extensively drug-resistant tuberculosis: 2 years of surveillance in Iran. Clin. Infect. Dis. 43:7 (2006), 841–847.
72. Masjedi, M., Tabarsi, P., Chitsaz, E., Baghaei, P., Mirsaeidi, M., Amiri, M.V., Farnia, P., Javanmard, P., Mansouri, D., Velayati, A.A., Outcome of treatment of MDR-TB patients with standardised regimens, Iran, 2002–2006. Int. J. Tuberc. Lung. Dis. 12:7 (2008), 750–755.
73. Masjedi, M.R., Tabarsi, P., Marjani, M., Shiva, P.B., Nasehi, M., Gooya, M.M., Farnia, P., Velayati, A.A., Management of MDR-TB: review of Iran's experience. Tanaffos 12:1 (2013), 6–15.
74. Mativandlela, S.P.N., Lall, N., Meyer, J.J.M., Antibacterial, antifungal and antitubercular activity of (the roots of) Pelargonium reniforme (CURT) and Pelargonium sidoides (DC) (Geraniaceae) root extracts. S. Afr. J. Bot. 72 (2006), 232–237.
75. Mehta, P.K., King, C.H., White, E.H., Murtagh, J., Quinn, F.D., Comparison of in vitro models for the study of Mycobacterium tuberculosis invasion and intracellular replication. Infect. Immun. 64:7 (1996), 2673–2679.
76. Mehta, A., Srivastva, G., Kachhwaha, S., Sharma, M., Kothari, S., Antimycobacterial activity of Citrullus colocynthis (L.) Schrad. against drug sensitive and drug resistant Mycobacterium tuberculosis and MOTT clinical isolates. J. Ethnopharmacol. 149:1 (2013), 195–200.
77. Meyer, J.J.M., Lall, N., Mathekga, A.D.M., Jäger, A.K., In vitro inhibition of drug-resistant and drug-sensitive strains of Mycobacterium tuberculosis by Helichrysum caespititium. S. Afr. J. Bot. 68:1 (2002), 90–93.
78. Millard, J., Ugarte-Gil, C., Moore, D.A., Multidrug resistant tuberculosis. BMJ, 350, 2015, h882.
79. Mishra, R., Shukla, P., Huang, W., Hu, N., Gene mutations in Mycobacterium tuberculosis: Multidrug-resistant TB as an emerging global public health crisis. Tuberculosis (Edinb) 95:1 (2015), 1–5.
80. Mohamad, S., Zin, N.M., Wahab, H.A., Ibrahim, P., Sulaiman, S.F., Zahariluddin, A.S., Noor, S.S., Antituberculosis potential of some ethnobotanically selected Malaysian plants. J. Ethnopharmacol. 133:3 (2011), 1021–1026.
81. Nair, C.K.N., Medicinal plants of India. 1998, Nag Publishers, New Delhi.
82. Nam, K.W., Jang, W.S., Jyoti, M.A., Kim, S., Lee, B.E., Song, H.Y., In vitro activity of (-)-deoxypergularinine, on its own and in combination with anti-tubercular drugs, against resistant strains of Mycobacterium tuberculosis. Phytomedicine 23:5 (2016), 578–582.
83. Namita, P., Mukesh, R., Medicinal Plants used as antimicrobial agents: review. Int. Res. J. Pharm. 3 (2012), 31–40.
84. Newman, D.J., Cragg, G.M., Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 70:3 (2007), 461–477.
85. Nguta, J.M., Appiah-Opong, R., Nyarko, A.K., Yeboah-Manu, D., Addo, P.G.A., Medicinal plants used to treat TB in Ghana. Int. J. Mycobacteriol. 4:2 (2015), 116–123.
86. Nguyen, L., Antibiotic resistance mechanisms in M. tuberculosis: an update. Arch. Toxicol. 90:7 (2016), 1585–1604.
87. Nieves, K., Prudhomme, J., Le Roch, K.G., Franzblau, S.G., Rodríguez, A.D., Natural product-based synthesis of novel anti-infective isothiocyanate-and isoselenocyanate-functionalized amphilectane diterpenes. Bioorg. Med. Chem. Lett. 26:3 (2016), 854–857.
88. Ofukwu, R.A., Ayoola, A., Akwuobu, C.A., Medicinal plants used in the treatment of tuberculosis in humans and animals by Idoma tribe of North-central Nigeria. Nig. Vet. J. 29:2 (2008), 25–30.
89. Ogbole, O.O., Ajaiyeoba, E.O., Traditional management of tuberculosis in Ogun State of Nigeria: the practice and ethnobotanical survey. Afr. J. Tradit. Complement. Altern. Med. 7:1 (2010), 79–84.
90. Orodho, J.A., Okemo, P., Otieno, N., Kirimuhuzya, C.M.J.J., Indigenous knowledge of communities around Lake Victoria Basin regarding treatment and management of tuberculosis using medicinal plants. Int. J. Med. Med. Sci. 6 (2014), 16–23.
91. Parrish, N.M., Dick, J.D., Bishai, W.R., Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol. 6:3 (1998), 107–112.
92. Paulson, T., Epidemiology: a mortal foe. Nature 502 (2013), S2–S3.
93. Poonam, K., Singh, G.S., Ethnobotanical study of medicinal plants used by the Taungya community in Terai Arc Landscape, India. J. Ethnopharmacol. 123:1 (2009), 167–176.
94. Prabhu, A., Antimycobacterial activity of certain mangrove plants against multi-drug resistant Mycobacterium tuberculosis. Asian J. Med Sci. 5:3 (2014), 54–57.
95. Radji, M., Kurniati, M., Kiranasari, A., Comparative antimycobacterial activity of some Indonesian medicinal plants against multi-drug resistant Mycobacterium tuberculosis. J. App. Pharm. Sci. 5:1 (2015), 019–022.
96. Rajani, S.D., Desai, P.B., Rajani, D.P., Anti-mycobacterial activity of garlic (Allium sativum) against multi-drug resistant and reference strain of Mycobacterium tuberculosis. Int. J. Appl. Res. 1:13 (2015), 767–770.
97. Rajasekar, T., Anbarasu, S., Manikkam, R., Joseph, J., Kumar, V., Inhibitory activity of Euphorbia hirta (Tawa-tawa) extracts against Mycobacterium tuberculosis and other non mycobacterial pathogens. Der Pharma Chemica 7:8 (2015), 213–216.
98. Ratnakar, P., Murthy, P.S., Preliminary studies on the antitubercular activity and the mechanism of action of the water extract of garlic (Allium sativum) and its two partially purified proteins (Garlic defensins?). Indian J. Clin. Biochem. 11:1 (1996), 37–41.
99. Saganuwan, A.S., Some medicinal plants of Arabian Pennisula. Med. Plants Res. 4 (2010), 766–788.
100. Samad, A., Sultana, Y., Akhter, M.S., Aqil, M., Treatment of tuberculosis: use of active pharmaceuticals. Recent Pat. Antiinfect. Drug Discov. 3 (2008), 34–44.
101. Samal, J., Ayurvedic management of pulmonary tuberculosis: a systematic review. J. Intercult. Ethnopharmacol. 5:1 (2016), 86–91.
102. Sansinenea, E., Ortiz, A., Antimycobacterial natural products from marine Pseudopterogorgia elisabethae. Curr. Org. Synth. 13:4 (2016), 556–568.
103. Silva, J.P., Appelberg, R., Gama, F.M., Antimicrobial peptides as novel anti-tuberculosis therapeutics. Biotechnol. Adv. 34:5 (2016), 924–940.
104. Singh, R., Hussain, S., Verma, R., Sharma, P., Anti-mycobacterial screening of five Indian medicinal plants and partial purification of active extracts of Cassia sophera and Urtica dioica. Asian Pac. J. Trop. Med. 6:5 (2013), 366–371.
105. Smith, I., Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin. Microbiol. Rev. 16:3 (2003), 463–496.
106. Smith, C.B., Battin, M.P., Jacobson, J.A., Francis, L.P., Botkin, J.R., Asplund, E.P., Domek, G.J., Hawkins, B., Are there characteristics of infectious diseases that raise special ethical issues?. Dev. World Bioeth. 4:1 (2004), 1–16.
107. Storey, C., Salem, J.I., Lay use of amazonian plants for the treatment of tuberculosis. Acta Amaz. 27:3 (1997), 175–182.
108. Sureram, S., Senadeera, S.P., Hongmanee, P., Mahidol, C., Ruchirawat, S., Kittakoop, P., Antimycobacterial activity of bisbenzylisoquinoline alkaloids from Tiliacora triandra against multidrug-resistant isolates of Mycobacterium tuberculosis. Bioorg. Med. Chem. Lett. 22:8 (2012), 2902–2905.
109. Tabuti, J.R.S., Kukunda, C.B., Waako, P.J., Medicinal plants used by traditional medicine practitioners in the treatment of tuberculosis and related ailments in Uganda. J. Ethnopharmacol. 127:1 (2010), 130–136.
110. Talavera, W., Miranda, R., Lessnau, K., Klapholz, A., Extrapulmonary Tuberculosis. Tuberculosis: Current Concepts And Treatment. 2nd ed., 2001, CRC Press, Inc, Boca Raton, Fla, 139–190.
111. Tascon, R., Soares, C., Ragno, S., Stavropoulos, E., Hirst, E., Colston, M., Mycobacterium tuberculosis-activated dendritic cells induce protective immunityin mice. Immunology 99:3 (2000), 473–480.
112. Tewari, U., Bahadur, A.N., Soni, P., Study of some Ethno Medicinal plants cultivated in Botanical garden, Science College, Bilaspur (C.G.). Int. J. Adv. Res. Biol. Sci. 2 (2015), 353–359.
113. Tiemersma, E.W., Van der Werf, M.J., Borgdorff, M.W., Williams, B.G., Nagelkerke, N.J., Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. PloS one, 6, 2011, e17601.
114. Tran, A.T., Watson, E.E., Pujari, V., Conroy, T., Dowman, L.J., Giltrap, A.M., Pang, A., Wong, W.R., Linington, R.G., Mahapatra, S., Saunders, J., Charman, S.A., West, N.P., Bugg, T.D., Tod, J., Dowson, C.G., Roper, D.I., Crick, D.C., Britton, W.J., Payne, R.J., Sansanmycin natural product analogues as potent and selective anti-mycobacterials that inhibit lipid I biosynthesis. Nat Commun., 8, 2017, 14414.
115. Uc-Cachón, A., Molina-Salinas, G., Said-Fernández, S., Méndez-González, M., Cáceres-Farfán, M., Borges-Argáez, R., A new dimeric naphthoquinone from Diospyros anisandra. Nat. Prod. Res. 27:13 (2013), 1174–1178.
116. Uc-Cachón, A.H., Borges-Argáez, R., Said-Fernández, S., Vargas-Villarreal, J., González-Salazar, F., Méndez-González, M., Cáceres-Farfán, M., Molina-Salinas, G.M., Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains. Pulm. Pharmacol. Ther. 27:1 (2014), 114–120.
117. Velayati, A.A., Farnia, P., Masjedi, M.R., Letter to Editor Recurrence after treatment success in pulmonary multidrug-resistant tuberculosis: predication by continual PCR positivity. Int. J. Clin. Exp. Med. 5:3 (2012), 271–272.
118. Viswanathan, V., Phadatare, A.G., Mukne, A., Antimycobacterial and antibacterial activity of Allium sativum bulbs. Indian J. Pharm. Sci. 76:3 (2014), 256–261.
119. Wang, J.F., Dai, H.Q., Wei, Y.L., Zhu, H.J., Yan, Y.M., Wang, Y.H., Long, C.L., Zhong, H.M., Zhang, L.X., Cheng, Y.X., Antituberculosis agents and an inhibitor of the para-aminobenzoic acid biosynthetic pathway from Hydnocarpus anthelminthica Seeds. Chem. Biodivers. 7:8 (2010), 046–053.
120. Wang, M., Guan, X., Chi, Y., Robinson, N., Liu, J.P., Chinese herbal medicine as adjuvant treatment to chemotherapy for multidrug-resistant tuberculosis (MDR-TB): a systematic review of randomised clinical trials. Tuberculosis 95 (2015), 364–372.
121. Warrier, P.K., Indian Medicinal Plants. 2002, Orient Longman, Hyderabad.
122. Wayne, L.G., Sohaskey, C.D., Nonreplicating persistence of Mycobacterium tuberculosis. Annu. Rev. Microbiol. 55 (2001), 139–163.
123. World Health Organization (WHO), Medicinal Plants in the South Pacific. 1998, World Health Organization, Regional Office for the Western Pacific in Manila, Philippines.
124. World Health Organization (WHO), The Use of Bedaquiline in the Treatment of Multidrug-resistant Tuberculosis: Interim Policy Guidance. 2013.
125. World Health Organization (WHO), Global Tuberculosis Report. 2015.
126. World Health Organization (WHO), Global Tuberculosis Report. 2016, World Health Organization, 2015.
127. Zhang, L., Li, R., Li, M., Qi, Z., Tian, J., In vitro and in vivo study of anti-tuberculosis effect of extracts isolated from Ranunculi Ternati Radix. Sarcoidosis Vasc. Diffuse. Lung Dis. 31:4 (2015), 336–342.